Alkermes : ALKS

All Alkermes Articles

94 Articles

Jon C. Ogg | Oct 16, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

The top analyst upgrades, downgrades and other research calls from Monday include Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66…

Jon C. Ogg | Oct 3, 2017 at 10:55 AM EDT

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of…

Jon C. Ogg | Jun 13, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Cheniere, Con-Ed, Foot Locker, Shopify, Tesla, Veeco, Zoetis and Many More

The top analyst upgrades, downgrades and other research calls from Tuesday include Cheniere Energy, Consolidated Edison, Foot Locker, Shopify, Tesla,…

Jon C. Ogg | Mar 31, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Alcoa, Amazon, ArcelorMittal, Corning, Intel, Vale, AMD and More

The top analyst upgrades, downgrades and initiations seen on Friday include Aerojet Rocketdyne, Alcoa, Amazon.com, ArcelorMittal, Corning, Intel, Vale and…

Lee Jackson | Oct 25, 2016 at 10:10 AM EDT

Hot Tech and Biotech Companies Highlight Jefferies Stocks to Buy

While worries about interest rates increases remain, it looks as though growth stocks still are the best avenue heading into…

Jon C. Ogg | Oct 24, 2016 at 7:55 AM EDT

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Is it possible that analysts are now behind the curve on Alkermes? Or worse, are they chasing their expectations too…

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Chris Lange | Jan 23, 2016 at 10:15 AM EST

4 Stocks That Punished Shareholders Last Week

While these were not the four biggest absolute losers of the week, they all issued news or had news that…

Chris Lange | Jan 21, 2016 at 9:15 AM EST

Why Alkermes Top-Line Results Might Not Be as Bad as Once Thought

Alkermes absolutely tanked early Thursday morning on less than favorable preliminary top-line results from the first two of three Phase…

Jon C. Ogg | Sep 30, 2015 at 2:40 PM EDT

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

A report on Wednesday from Janney Capital Markets has targeted several iotech bcompanies it believes are now grossly oversold.

Lee Jackson | Sep 25, 2015 at 9:50 AM EDT

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

In a recent research report, Jefferies highlighted three top biotech companies that are very tempting buys now.

Jon C. Ogg | Sep 1, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and Many More

Tuesday's top analyst upgrades, downgrades and initiations include American Airlines, CyberArk Software, Delta Air Lines, First Solar and VMware.

Chris Lange | Aug 6, 2015 at 2:20 PM EDT

5 Big FDA Decisions Expected in August

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and…

Chris Lange | Jul 7, 2015 at 7:35 AM EDT

5 Big Upcoming FDA Decisions Expected in July

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and…

Jon C. Ogg | May 21, 2015 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

Thursday's top analyst upgrades, downgrades and initiations include Alibaba, Mobileye, NetApp, Nike, Salesforce.com and Stratasys.

1 2 3 4 5 … 7

Alkermes : ALKS

All Alkermes Articles

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Top Analyst Upgrades and Downgrades: Cheniere, Con-Ed, Foot Locker, Shopify, Tesla, Veeco, Zoetis and Many More

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Alcoa, Amazon, ArcelorMittal, Corning, Intel, Vale, AMD and More

Hot Tech and Biotech Companies Highlight Jefferies Stocks to Buy

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

4 Stocks That Punished Shareholders Last Week

Why Alkermes Top-Line Results Might Not Be as Bad as Once Thought

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and Many More

5 Big FDA Decisions Expected in August

5 Big Upcoming FDA Decisions Expected in July

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

QYLD’s $10,000 Problem: How a Covered-Call ETF Left Investors With a Fraction of Nasdaq Gains

The HSA Move High Earners Are Prioritizing Over 401(k) Catch-Up Contributions in 2026

The $82 Annual Fee Is Just the Start: TQQQ’s Hidden Cost Structure Explained

The HSA Move High Earners Are Prioritizing Over 401(k) Catch-Up Contributions in 2026

Your First Required IRA Withdrawal at 73 Can Push You Past the IRMAA Cliff for a Full Year

QYLD’s $10,000 Problem: How a Covered-Call ETF Left Investors With a Fraction of Nasdaq Gains

The HSA Move High Earners Are Prioritizing Over 401(k) Catch-Up Contributions in 2026

Alkermes : ALKS

All Alkermes Articles

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Top Analyst Upgrades and Downgrades: Cheniere, Con-Ed, Foot Locker, Shopify, Tesla, Veeco, Zoetis and Many More

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Alcoa, Amazon, ArcelorMittal, Corning, Intel, Vale, AMD and More

Hot Tech and Biotech Companies Highlight Jefferies Stocks to Buy

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

4 Stocks That Punished Shareholders Last Week

Why Alkermes Top-Line Results Might Not Be as Bad as Once Thought

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and Many More

5 Big FDA Decisions Expected in August

5 Big Upcoming FDA Decisions Expected in July

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

QYLD’s $10,000 Problem: How a Covered-Call ETF Left Investors With a Fraction of Nasdaq Gains

The HSA Move High Earners Are Prioritizing Over 401(k) Catch-Up Contributions in 2026

The $82 Annual Fee Is Just the Start: TQQQ’s Hidden Cost Structure Explained

Featured Reads

The HSA Move High Earners Are Prioritizing Over 401(k) Catch-Up Contributions in 2026

Your First Required IRA Withdrawal at 73 Can Push You Past the IRMAA Cliff for a Full Year